Abstract
It was found that renal cancer tissue is characterized by increased content of VEGF not depending on the parameters of normal tissue and expression of VEGFR2 receptor. At the same time, the content of VEGFR2 in the tumor is determined by the state of the surrounding tissue and increases in low number of patients with tumors invading the renal capsule. Serum concentrations of VEGF and VEGFR2 in patients with renal cancer did not significantly differ from the corresponding values in the control group. No significant correlations between the levels of VEGF and VEGFR2 in the blood and tumor tissue were found.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E. A. Kim, E. S. Gershtein, I. V. Vysotskaya, and N. E. Kushkinsky, Byull. Eksp. Biol. Med., 145, No. 2, 206–209 (2008).
A. M. Shcherbakov, E. C. Gershtein, O. A. Anurova, and N. E. Kushlinsky, Vopr. Onkol., 51, No. 3, 317–321 (2005).
F. I. Alamdari, T. Rasmuson, K. Grankvist, et al., Scand. J. Urol. Nephrol., 41, No. 1, 5–9 (2007).
M. J. Cross, J. Dixelius, T. Matsumoto, and L. Claesson-Welsh, Trends Biochem. Sci., 28, No. 9, 488–494 (2003).
G. Djordjevic, V. Mozetic, D. V. Mozetic, et al., Pathol. Res. Pract., 203, No. 2, 99–106 (2007).
D. Y. Heng, B. I. Rini, J. Garcia, et al., Clin. Genitourin. Cancer., 5, No. 7, 446–451 (2007).
J. Jacobsen, K. Grankvist, T. Rasmuson, et al., BJU Int., 93, 297–302 (2004).
J. Jacobsen, T. Rasmuson, K. Grankvist, et al., J. Urol., 163, No. 1, 343–347 (2000).
B. Ljungberg, J. Jacobsen, S. Haggstrom-Rudolfsson, et al., Urol. Res., 31, No. 5, 335–340 (2003).
D. Pouessel, S. Culine, G. Verhoest, et al., Presse Med., 37, No. 4, Pt. 2, 628–633 (2008).
M. Raica, A. M. Cimpean, and A. Anghel, Neoplasma, 54, No. 4, 278–284 (2007).
B. I. Rini and E. J. Small, J. Clin. Oncol., 23, 1028–1043 (2005).
L. Ryden, B. Linderholm, N. H. Nielsen, et al., Breast Cancer Res. Treat., 82, No. 3, 147–154 (2003).
K. Sato, N. Tsuchiya, R. Sasaki, et al., Jpn. J. Cancer Res., 90, No. 8, 874–879 (1999).
L. Schips, O. Dalpiaz, K. Lipsky, et al., Eur. Urol., 51, No. 1, 168–173 (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 145, No. 6, pp. 691–694, June, 2008
Rights and permissions
About this article
Cite this article
Kushlinsky, N.E., Trapeznikova, M.F., Gershtein, E.S. et al. Vascular endothelial growth factor and its type 2 receptor in tumors and serum of patients with renal cancer. Bull Exp Biol Med 145, 744–747 (2008). https://doi.org/10.1007/s10517-008-0188-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-008-0188-1